Get free email notifications about insider trading in METABASIS THERAPEUTICS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of insider trading in METABASIS THERAPEUTICS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in METABASIS THERAPEUTICS INC for free.

CIK Number: 0001053221
IRS Number: 330753322
Trading Symbol: MBRX
Company Address: 9390 TOWNE CENTRE DRIVE SAN DIEGO 92121

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company, which engages in the development of treatments for highly resistant cancers and viruses. Its clinical stage drugs include Annamycin, an Anthracycline being studied for the treatment of relapsed or refractory acute myeloid leukemia (AML), and WP1066, an Immune/Transcription Modulator targeting brain tumors, pancreatic cancer, and AML. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe on July 28, 2015 and is headquartered in Houston, TX.

Market Capitalization: $18.08M
Prev close: $1.80
Average Daily Volume: 157,258
Days Low: $1.50
Year Low: $1.41
Year High: $9.58

METABASIS THERAPEUTICS INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 29 2010MBRXMETABASIS THERAPEU ...EVNIN LUKEDirectorSellD0.004,814,725004.8 M to 0 (-100.00 %)
Jan 29 2010MBRXMETABASIS THERAPEU ...MPM BIOVENTURES II QP LP10% OwnerSellD0.004,814,725004.8 M to 0 (-100.00 %)
Jun 25 2009MBRXMETABASIS THERAPEU ...Stoner ElizabethDirectorOption ExerciseA0.4110,0004,10010,000
Jun 25 2009MBRXMETABASIS THERAPEU ...EVNIN LUKEDirectorOption ExerciseA0.4110,0004,10010,000
Jun 25 2009MBRXMETABASIS THERAPEU ...Laikind Paul KDirectorOption ExerciseA0.415,0002,0505,000
Jun 25 2009MBRXMETABASIS THERAPEU ...HALE DAVID FDirectorOption ExerciseA0.4110,0004,10010,000
Jun 24 2009MBRXMETABASIS THERAPEU ...Schreiner GeorgeDirectorOption ExerciseA0.4110,0004,10010,000
Jun 24 2009MBRXMETABASIS THERAPEU ...ROHN WILLIAM RDirectorOption ExerciseA0.4110,0004,10010,000
Jun 24 2009MBRXMETABASIS THERAPEU ...ORONSKY ARNOLD LDirectorOption ExerciseA0.4110,0004,10010,000
Jun 24 2009MBRXMETABASIS THERAPEU ...BURGESS DANIEL DDirectorOption ExerciseA0.4110,0004,10010,000
Mar 02 2009MBRXMETABASIS THERAPEU ...Nguyen TranVP and CFOOption ExerciseA0.35250,00087,500250,000
Feb 02 2009MBRXMETABASIS THERAPEU ...Erion Mark DChief Executive Off ...Option ExerciseD1.00240,000240,000240,000
Feb 02 2009MBRXMETABASIS THERAPEU ...Erion Mark DChief Executive Off ...Option ExerciseD2.1090,000189,0000
Feb 02 2009MBRXMETABASIS THERAPEU ...Erion Mark DChief Executive Off ...Option ExerciseD7.5575,000566,2500
Feb 02 2009MBRXMETABASIS THERAPEU ...Erion Mark DChief Executive Off ...Option ExerciseD9.0375,000677,2500

View all METABASIS THERAPEUTICS INC insider transactions.